Cargando…
Should Genetic Testing for Cancer Predisposition Be Standard-of-Care for Women with Invasive Breast Cancer? The Murtha Cancer Center Experience
Currently, genetic testing is offered only to women diagnosed with breast cancer who meet a defined set of criteria and is not included as standard-of-care treatment at the time of diagnosis. Thus, a significant number of women diagnosed with breast cancer may miss the opportunity for precision medi...
Autores principales: | Rummel, Seth K., Lovejoy, Leann A., Turner, Clesson E., Shriver, Craig D., Ellsworth, Rachel E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016980/ https://www.ncbi.nlm.nih.gov/pubmed/31963545 http://dx.doi.org/10.3390/cancers12010234 |
Ejemplares similares
-
Cancer Previvors in an Active Duty Service Women Population: An Opportunity for Prevention and Increased Force Readiness
por: Lovejoy, Leann A, et al.
Publicado: (2021) -
Eligibility, uptake and response to germline genetic testing in women with DCIS
por: Turza, Lauren, et al.
Publicado: (2022) -
Heritability of Low ER Staining/HER2-Breast Tumors: Are We Missing an Opportunity for Germline Testing?
por: Lovejoy, Leann A., et al.
Publicado: (2020) -
Survival Disparities in US Black Compared to White Women with Hormone Receptor Positive-HER2 Negative Breast Cancer
por: Lovejoy, Leann A., et al.
Publicado: (2023) -
Relationship between Cigarette Smoking and Cancer Characteristics and Survival among Breast Cancer Patients
por: Darmon, Sarah, et al.
Publicado: (2022)